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OBJECTIVE: Relatively little attention has been paid to emotional outcome after
subarachnoid hemorrhage (SAH). This study assessed levels of anxiety and depression
among SAH survivors and related these to clinical indices.
METHODS: Seventy SAH patients from a consecutive series of neurosurgical
admissions participated in semistructured assessments of functional outcome; 52 of
the patients also returned standardized measures of emotional outcome. These data
were compared with clinical indices collected during the initial hospital
admission.
RESULTS: Moderate to severe levels of anxiety were present in approximately 40%
of patients 16 months after hemorrhage, with approximately 20% experiencing
moderate to severe levels of depression. Although anxiety was more likely to be
reported at interview by those with an SAH of Fisher Grade 4, the standardized
measures of anxiety and depression were not associated with severity of hemor-
rhage or any other clinical variables. Both anxiety and depression were signifi-
cantly associated with outcome indices such as return to work and engagement in
social activities.
CONCLUSION: Anxiety is a significant and lasting problem for approximately 40% of
survivors of SAH. It is suggested that measures taken to prevent or treat such anxiety
among survivors of SAH may serve to significantly improve functional outcome.
KEY WORDS: Anxiety, Depression, Emotion, Outcome, Subarachnoid hemorrhage
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In recent years, survival rates have improved among pa-tients who have experienced a subarachnoid hemorrhage(SAH), and the incidence of physical disability among
survivors has declined (8). As interest has increased in func-
tional outcome among survivors, a number of outcome studies
have reported cognitive impairments, particularly memory
and concentration deficits, after SAH (2, 9–12, 14, 16, 17). More
recently, some studies have reported on the incidence of de-
pressive illness after SAH (2, 11, 15, 22).
Relatively little attention has been paid to other measures of
emotional outcome, such as anxiety, despite evidence suggest-
ing that this is an important factor in the functional outcome of
these patients (2, 20, 22). A short report has drawn attention to
the presence of posttraumatic stress disorder in 32% of SAH
patients referred to a behavioral clinic, with anxiety found to
be the main presenting problem in another 18% of patients (1).
However, few studies have examined anxiety and depression
in representative samples of SAH patients or have been able to
compare these consequences with clinical indices collected
during the initial hospital admission.
PATIENTS AND METHODS
Patients
The study group comprised 84 surviving patients with con-
firmed spontaneous SAH derived from a consecutive series
described previously (4). SAH was confirmed by computed
tomography or lumbar puncture. No contact could be estab-
lished with 7 patients, 6 patients either declined to participate
or repeatedly did not attend arranged appointments, and 1
patient lived a considerable distance from the unit. Of the 70
remaining patients, 43 (61%) were female, and the mean age
was 45.2 years (standard deviation, 15.2 yr; range, 25–74 yr).
Mean years of education was 12.21 years (standard deviation,
2.1 yr; range, 9–19 yr). The majority (80%) were married or in
a stable cohabiting relationship.
Procedure
Clinical variables, including World Federation of Neurolog-
ical Surgeons (WFNS) grade (24, 27) and Fisher grade (5), were
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recorded during hospital admissions at the Department of
Neurosurgery in Glasgow’s Southern General Hospital (Tables
1 and 2). Of the 56 patients with an SAH of confirmed aneu-
rysmal origin, 54 underwent a procedure; of these, 8 under-
went endovascular treatment, and the remaining 46 under-
went craniotomy with clipping. Surgery was undertaken a
median of 5 days after admission (range, 0–52 d), with only 3
cases exceeding 14 days. Information about emotional adjust-
ment after SAH was collected as part of a study of genetic
influences on outcome in which the 70 SAH patients were
followed up by semistructured interview and cognitive tasks
(PG Morris, submitted for publication). The mean time be-
tween initial admission to the neurosurgical unit and
follow-up assessment was 16.3 months (standard deviation,
2.1 mo; range, 14–23 mo). The extended Glasgow Outcome
Scale was also administered as part of the interview (25).
Questionnaires
Questionnaires were given to patients at the end of the
interview; they were to be completed at home and returned.
These questionnaires comprised the following well-
standardized measures, each of which has been used previ-
ously in studies of outcome after brain injury. Fifty-two pa-
tients (74%) returned these questionnaires, most within 1
month of the interview.
Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) (28) is
a brief, 14-item scale divided equally into questions relating to
anxiety or depression. It uses questions that are designed to
minimize the confounding influence of physical health prob-
lems and has been used previously in outcome studies of SAH
(7), other strokes (3), and traumatic head injury.
TABLE 1. Clinical variables in different study groupsa
No. of patients (%)
Eligible study group
(n  84)
Attended interview
(n  70)
Returned questionnaires
(n  52)
Fisher grade
0b 1 (1.2) 1 (1.4) 0
1 8 (9.5) 6 (8.6) 5 (9.6)
2 6 (7.1) 6 (8.6) 5 (9.6)
3 43 (51.2) 37 (52.9) 30 (57.7)
4 26 (31.0) 20 (28.5) 12 (23.1)
WFNS grade
I 58 (69.0) 47 (67.1) 40 (76.9)
II 13 (15.5) 12 (17.1) 5 (9.6)
III 2 (2.4) 2 (2.9) 1 (1.9)
IV 3 (3.6) 3 (4.3) 3 (5.8)
V 8 (9.5) 6 (8.6) 3 (5.8)
Confirmed aneurysm 68 (81.0) 56 (80.0) 42 (80.8)
Negative angiogram 14 (16.6) 12 (17.1) 9 (17.3)
Unknown (no angiogram) 2 (2.4) 2 (2.9) 1 (1.9)
a WFNS, World Federation of Neurological Surgeons.
b No computed tomographic scan; hemorrhage confirmed by lumbar puncture.
TABLE 2. Fisher grading scalea
Fisher grade Description
0 No scan available
1 No blood detected
2 Diffuse deposition or thin layer. All vertical layers
of blood 1 mm thick
3 Localized clots and/or vertical layers of blood 1
mm thick
4 Intraventricular or intraparenchymal blood present
with diffuse or no subarachnoid hemorrhage
a Adapted from, Fisher CM, Kistler JP, Davis JM: Relation of cerebral
vasospasm to subarachnoid hemorrhage visualized by computerized to-
mographic scanning. Neurosurgery 6:1–9, 1980 (5).
MORRIS ET AL.
48 | VOLUME 54 | NUMBER 1 | JANUARY 2004 www.neurosurgery-online.com
General Health Questionnaire
The 30-item version of the General Health Questionnaire
(GHQ-30) is widely used in health outcome studies and ex-
cludes physical health-related items present in the 60-item
version (6). Thresholds for the GHQ-30 suggested to be more
appropriate for stroke survivors (18) are reported in addition
to those suggested by the original authors to allow compari-
sons with other studies.
The Beck Depression Inventory
The Beck Depression Inventory is a widely used 21-item
measure designed to assess severity of depressive illness in
adolescents and adults. It has been used in a number of studies
to measure depression after SAH (2, 11, 15, 16) and head injury
(26).
State-Trait Anxiety Inventory
The State-Trait Anxiety Inventory measures state and trait
anxiety separately, with trait anxiety referring to relatively
stable differences in anxiety proneness and state anxiety re-
ferring to anxiety present at a given time (21). It was used in
one of the first studies of SAH outcome to include a measure
of anxiety (22) and was included here to allow comparison.
Analyses
Nonparametric tests were used because of the ordinal na-
ture of these measures of emotional outcome. The associations
between clinical grades and outcome measures were analyzed
with Spearman correlations. For 2 analyses, clinical grades
were collapsed into the dichotomized groupings of Fisher
Grade 4 versus Fisher Grades 1 to 3 and WFNS Grade I versus
WFNS Grades II to V.
RESULTS
Reported Symptoms at Interview
Levels of anxiety were reported to have worsened since the
hemorrhage by 33 patients (47%) at interview, whereas de-
pression was reported to have worsened by 34 (49%). Anxiety
was more likely to be reported by those with a Fisher grade of
4 (2  8.33, P  0.004), although there were no associations
with WFNS grade or aneurysmal origin, and there were no
significant relationships between reported depression and any
of the clinical variables. By the time of the interview, 33
(63.5%) of the 52 patients who had been working before the
hemorrhage had returned to work, of whom all but 2 had
returned to the same job, and the majority believed themselves
to be coping as well now as before the hemorrhage. However,
those who had not returned to work were significantly more
likely to report elevated levels of anxiety (58 versus 18%, 2 
9.13, P  0.003) and depression (64 versus 11%, 2  15.66, P
 0.001) than those who had returned to work.
More than half of the patients reported that their social and
leisure activities were still reduced 16 months after the hem-
orrhage. This reduction in social activities was substantial in
29 patients (41%), with these substantial reductions in social
activity significantly more likely in those who reported anxi-
ety (58 versus 27%, 2  6.71, P  0.01) or depression (65
versus 19%, 2  14.76, P  0.001).
Questionnaires
The questionnaires were returned by 52 patients (74%),
although 6 patients did not fully complete the GHQ-30. There
were no notable or statistical differences in clinical or demo-
graphic variables between those who attended the interview
and those who returned questionnaires (Table 1). However,
those who reported increased anxiety or depression in the
interviews were less likely to return the questionnaires. Of
those who reported being more depressed, 65% returned
questionnaires, relative to 83% of those not reporting depres-
sion. Similarly, 64% who reported being more anxious re-
turned questionnaires, relative to 84% who did not report
anxiety at interview.
On the HADS anxiety subscale, 16% of the SAH survivors
had scores indicating mild anxiety, with another 38% having
scores indicating moderate or severe levels of anxiety (Fig. 1).
Virtually all of those scoring in the moderate or severe anxiety
range reported feelings of panic either quite often or very
often. Scores on the State-Trait Anxiety Inventory also dem-
onstrated high levels of anxiety, with 58% of patients scoring
above the 80th percentile on trait anxiety and 46% scoring
above the 80th percentile on state anxiety. Although 21% of
patients had scores on the HADS depression scale indicating
mild depression, clinical levels of depression were lower than
corresponding levels of anxiety, with only 17% scoring in the
moderate or severe depression range. These HADS depression
scores are broadly consistent with those on the Beck Depres-
sion Inventory, in which 28% of patients scored in the mild to
moderate depression range (10–18) and another 22% scored in
the moderate to severe depression range (19).
FIGURE 1. Distribution of patients at different levels of the HADS.
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Comparison with Interview Data
Reporting of anxiety or depression at interview was com-
pared with dichotomized HADS groupings (i.e., normal or
mild versus moderate or severe). Those who reported anxiety
at interview were significantly more likely to have moderate
to severe anxiety on the HADS than those who reported no
anxiety (68 versus 19%, 2  11.84, P  0.001) but were not
significantly more likely to have moderate to severe depres-
sion (29 versus 10%, 2  3.12, P  0.077). In contrast, those
who reported depression at interview were significantly more
likely to have both moderate to severe anxiety (64 versus 20%,
2 10.21, P 0.001) and depression (36 versus 3%, 2 9.68,
P 0.002). This stronger association between reported depres-
sion and measures of anxiety is largely because of seven
individuals who, despite reporting depression at interview,
scored in the normal to mild range on depression scales and in
the moderate to severe range on anxiety scales.
General Health Questionnaire
Nineteen (41%) of 46 patients who returned the fully com-
pleted GHQ-30 scored above the 4/5 threshold, with 15 (33%)
scoring above the more conservative 8/9 threshold, indicating
poor subjective mental health in at least one-third of these
patients. Outcome as determined by the extended Glasgow
Outcome Scale is shown in Table 3, with 11 (16%) having a
severe disability, 28 (40%) a moderate disability, and 31 (44%)
a good recovery. All of the anxiety and depression measures
were significantly correlated with extended Glasgow Out-
come Scale at a value of P  0.001.
Return to Work and Social Restriction
Thirty-six of those who returned questionnaires had been
working before the hemorrhage. Ability to return to previous
work was reduced both in those with moderate to severe
HADS depression (5 of 5 versus 14 of 31; P  0.047, Fisher’s
exact test) and in those with moderate to severe HADS anxiety
(10 of 13 versus 9 of 23; 2  4.76, P  0.029) relative to those
with normal or mild levels.
Social restriction was also significantly associated with both
anxiety and depression, with 9 of 9 patients with moderate to
severe HADS depression going out socially substantially less,
relative to 12 of 43 patients with normal or mild levels (2 
16.07, P 0.001) and 14 of 20 patients with moderate to severe
HADS anxiety going out substantially less, relative to 7 of 32
patients with normal or mild levels (2  11.84, P  0.001).
Relationship with Clinical Indices
Those individuals in the clinical anxiety range on the HADS
did not differ significantly in 2 testing from those with lower
anxiety scores in terms of Fisher grade, WFNS grade, aneu-
rysmal site, aneurysmal or nonaneurysmal origin, or sex.
There were no significant relationships between any clinical or
demographic variables and above-threshold GHQ scores.
Spearman correlations also found no significant associations
between measures of anxiety or depression and either clinical
grade, time from admission until surgery (after removal of
two outliers), or age at assessment.
DISCUSSION
This study reports emotional outcomes after SAH in a sam-
ple derived from consecutive admissions to a neurosurgical
unit. Although mild depression was present in a considerable
proportion of these SAH patients, anxiety was present at
clinical levels twice as frequently, with approximately 40% of
patients having moderate to severe anxiety levels. Thus, al-
though both anxiety and depression were reported by approx-
imately 48% of patients to have increased, anxiety was more
frequently present at clinical levels, whereas increases in de-
pression were often mild. Both anxiety and depression were
significantly correlated with reduced ability to return to work
and reduced social activity. Although causality cannot be
inferred from these correlations alone, comments from inter-
viewees suggested that whereas depression was often a con-
sequence of being unable to return to work or of social isola-
tion, anxiety was more frequently a cause for not being able to
return to work or participate in social activities.
Because those who reported increased anxiety or depression
at interview were equally less likely to have returned the
standardized questionnaires, it is probable that these mea-
sures may have underestimated the true prevalence of anxiety
and depression in this population. This bias, with anxious or
depressed individuals being less inclined to participate, is
likely to have been even more pronounced in studies that have
used opportunity samples rather than being derived from a
consecutive series.
It is uncertain whether this emotional disturbance would
decrease over time without intervention. One of the few stud-
ies to have investigated longer-term outcome after SAH found
that more than 15% reported increased anxiety approximately
TABLE 3. Distribution of patients on Extended Glasgow
Outcome Scalea
Outcome No. of SAH patients %
Lower severe disability 4 5.7%
Upper severe disability 7 10.0%
Lower moderate disability 9 12.9%
Upper moderate disability 19 27.1%
Lower good recovery 19 27.1%
Upper good recovery 12 17.1%
a SAH, subarachnoid hemorrhage.
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4 to 7 years later, indicating that these difficulties persist in at
least a proportion of survivors (17).
Comparison with Other Outcome Studies
A recent study of emotional outcome after stroke, which
excluded SAH, found that anxiety and depression were
present in approximately equivalent proportions, with 16%
and 12% scoring above 10 on the respective HADS subscales
(3). We report slightly higher levels of depression among SAH
survivors. However, far more notable is the strikingly higher
rate of anxiety, with more than double the percentage of SAH
patients (38%) scoring more than 10 on the HADS relative to
that reported for other types of stroke. This figure of approx-
imately 40% of SAH patients experiencing anxiety disorders is
also demonstrated by interview and State-Trait Anxiety In-
ventory data, such that it is unlikely to be an artifact of the
measure used. These higher levels of anxiety after SAH rela-
tive to other stroke types may relate in part to the younger age
at which patients typically experience SAH, with its life-
threatening occurrence invariably sudden and unexpected in
individuals who are often otherwise healthy.
Hellawell et al. (7) reported fewer anxiety problems in their
sample of SAH patients also drawn from consecutive admis-
sions and with broadly similar age and admission grades. It is
possible that this reflects some as yet unidentified difference in
either patient population or after-care practices, although their
data at 12 months are based on only 22 (52%) of 42 potential
patients, whereas we report interview data at 16 months from
70 (83%) of 84 patients, with questionnaire data from 52 (64%).
The study by Hellawell et al. does, however, report that 36%
of the relatives of SAH patients considered that anxiety/
tension in the patient had increased since the hemorrhage,
which is more consistent with the reporting of anxiety by
patients in our study.
Hutter et al. (11) reported that 36% of their patients reported
feeling strained and insecure socially, a figure that would be
broadly consistent with our study. Another study based on
patients referred to a clinical psychologist found that anxiety
was the main presenting problem in 50% of patients (1). An-
other 36% had experienced anxiety and memory difficulties at
the time of referral that had since resolved. Only 14% of
patients presented with cognitive impairment as the primary
problem.
Clinical Variables
There were no consistent associations between reported
emotional disturbance and any of the clinical variables mea-
sured. Although Fisher Grade 4 was associated with reporting
of anxiety in interviews, this association was not present in the
standardized measures in which level of anxiety is considered
rather than presence alone. Eight Fisher Grade 4 patients did
not return questionnaires, although they were no more likely
to have reported anxiety in the interview than those who did
return questionnaires. It is possible, however, that an effect of
Fisher Grade 4 on anxiety remains but that this effect was not
strong enough to be detected in the questionnaire sample.
Thus, it would seem that although WFNS and Fisher grades
are strongly associated with survival and physical/cognitive
outcome (12, 19, 23), they are either less strongly or not at all
associated with emotional outcome.
The relative absence of any strong association with clinical
grades suggests that the anxiety is likely to be either a conse-
quence of having experienced a sudden life-threatening event
or a response to changed circumstances after hemorrhage
rather than a direct organic consequence of brain injury.
Potential for Interventions
The high incidence of anxiety disorders after SAH and their
very substantial effects on quality of life are of particular
interest because anxiety disorders can generally be treated
more successfully than physical or cognitive disabilities. Thus,
the identification of these anxiety disorders and referral to a
clinical psychologist or other suitably trained professional
could potentially improve the functional outcome of these
patients.
It is also of interest to know why these anxiety disorders
develop in some individuals subsequent to SAH and not in
others. Although approximately 40% of patients experienced
significant anxiety, the remaining 60% seemed relatively un-
troubled despite broadly equivalent severity of hemorrhage
and comparable clinical grades. Although it is possible that
elevated levels of anxiety were present in these patients before
the hemorrhage, the majority of anxious patients reported no
previous psychological difficulties before the hemorrhage.
This suggests that subsequent emotional disturbances are trig-
gered primarily by the hemorrhage.
It is possible that the coping styles adopted by either the
patient or the caregiver(s) in response to the SAH may influ-
ence subsequent recovery and predisposition toward anxiety-
related disorders. The extent and format of information given
to patients and their families may also be a factor in influenc-
ing emotional outcome. Many of the patients and their care-
givers mentioned that they would have appreciated more
information in a format that was easy to understand. Rela-
tively simple, low-cost interventions may help to reduce anx-
iety among both patients and their families.
CONCLUSIONS
Approximately 40% of surviving SAH patients still experi-
ence significant levels of anxiety more than 16 months after
SAH. This anxiety seems to reduce the ability of these patients
to return to normal levels of social functioning and employ-
ment and as such may be a significant factor in their functional
outcome. Consequently, interventions aimed at reducing the
occurrence of such anxiety or at identifying and treating this
anxiety may substantially improve functional outcome among
these patients.
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The authors examined levels of anxiety and depressionamong survivors of subarachnoid hemorrhage (SAH) and
attempted to correlate these results with clinical indices. They
demonstrated moderate to severe levels of anxiety in approx-
imately 40% and moderate to severe levels of depression in
20% of patients 16 months after hemorrhage. In addition, they
found no correlation between clinical variables and standard-
ized measures of anxiety and depression but did find signifi-
cant associations with outcome indices such as return to work
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Functional outcome measures continue to assume increas-
ing importance in analyses of outcome in patients who have
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The traditional focus of neurosurgical follow-up has been
on physical well-being in these patients. However, as empha-
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sures and vigilance in the screening and treatment of these
disorders in the care of SAH patients may ultimately translate
into improved overall functional outcomes.
Aaron S. Dumont
Neal F. Kassell
Charlottesville, Virginia
The aim of this study was to assess the level of late clinicalanxiety and depression in consecutive patients treated for
SAH in one neurosurgical unit. Seventy of 84 patients with
confirmed spontaneous SAH were interviewed a mean of 16
months after the bleeding, but only 52 patients also filled out
four semistructured questionnaires at home and returned
them later. The tests included the Hospital Anxiety and De-
pression Scale (HADS), Beck Depression Inventory (BDI),
State-Trait Anxiety Inventory (STAI), and General Health
Questionnaire (GHQ-30). Of the 52 patients, 42 had an aneu-
rysm; in 10 patients, no aneurysm was found. The study
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showed that moderate or severe anxiety was present in ap-
proximately 40% (38% and 46%) of patients and moderate to
severe depression in approximately 20% (21% and 22%), but
the authors concluded that the symptoms were not associated
with any clinical variables during the treatment, such as the
severity of bleeding. Problems in returning to work and social
activities were strong indices of depressive symptoms and
anxiety. It was concluded that these symptoms often could
have been prevented or treated if they had been found early.
According to the interviews, social and leisure activities
were reduced substantially, especially in patients with anxiety
(58%) and depression (63%). At least 33% of the patients
showed poor subjective mental health, and 56% had either
severe or moderate disability on the extended Glasgow Out-
come Scale. Anxiety and depression correlated significantly
with grade on the extended Glasgow Outcome Scale. Al-
though Fisher Grade 4 was more often recorded in patients,
however, there was no correlation between standardized mea-
sures of anxiety, depression, and quality-of-life test scores and
Fisher grade, World Federation of Neurosurgical Societies
grade at arrival, origin of SAH, site of the aneurysm, timing of
the operation, or sex or age of the patient.
The message of the study is clear: after SAH with satisfac-
tory neurological recovery, many patients are not doing well;
they have psychosocial problems, anxiety, and depression.
The authors conclude that these symptoms are not caused by
vascular, mechanical, or ischemic injury per se but, rather, are
related to the experience of a life-threatening event in rela-
tively young patients, perhaps without the possibility of ade-
quate counseling. This is a reasonable explanation, and cer-
tainly more information, care, and prospective follow-up are
needed to prove it.
There is increasing interest in research on this subject; two
other articles on the topic have recently been published in Neu-
rosurgery (1, 2), and there is no doubt that the late psychosocial
and emotional complications of SAH have been undervalued in
many outcome studies of SAH. Buchanan et al. (1) found that the
majority of their patients with good surgical outcome reported
elevated levels of psychological stress, and the authors empha-
sized that the patients’ relatives reported even more severe prob-
lems. Both groups viewed the quality of life as worse than as
assessed by the operating neurosurgeon. In the follow-up of their
89 consecutive aneurysmatic SAH patients, Carter et al. (2) found
symptomatic late depression in 36%. The important series of
studies from Lund on neuropsychological outcome after early
aneurysm surgery in the mid-1980s also showed psychosocial
maladjustment after good neurological recovery in more than
30% (3, 4). The results of the present study confirm and define the
magnitude of the disturbed quality of life.
Matti Vapalahti
Kuopio, Finland
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The present study assesses levels of anxiety and depressionin survivors of SAH and attempts to relate these to various
clinical parameters. Follow-up assessment was performed by
interview of 70 SAH patients derived from a consecutive
series of neurosurgical admissions, and 55 of these 70 patients
also returned standardized measures of emotional outcome.
The mean time between initial admission and follow-up as-
sessment was 16.3 months (range, 14–23 mo). Interestingly,
this study found that moderate to severe levels of anxiety were
present in 40% of patients, and 20% experienced moderate to
severe levels of depression. The standardized measures of
anxiety and depression were not associated with severity of
hemorrhage or other clinical variables, although anxiety was
reported more frequently at interviews by those patients with
a Fisher Grade 4 hemorrhage. Not surprisingly, both anxiety
and depression were significantly associated with outcome
indices, including decreased return to work and reduced en-
gagement in social activities.
Although this study is not completely novel, because other
groups have examined post-SAH depression and, to a lesser
extent, post-SAH anxiety, the present study represents a large
series of patients and was rigorously conducted. The results
reported may have important implications for treatment of
surviving SAH patients. However, further studies will be
needed to determine whether treatment of such anxiety or
depression in SAH patients improves functional outcome.
Gary K. Steinberg
Stanford, California
Aneurysm surgeons dread the regular reminders we get fromboth the literature and our own patients’ neuropsychologists
and physiatrists on how cognitively impaired our surgical “suc-
cesses” actually are. This clinical study from Glasgow can now
add to our own personal despair because it shows that approx-
imately 40% of consecutive SAH survivors also experienced a
significant anxiety disorder more than a year after surgery, and
one in five was moderately to severely depressed. Interestingly,
these emotional rather than cognitive disorders were not espe-
cially associated with severity of hemorrhage, and one could
argue that less damaged and cognitively affected patients might
worry more about their condition and future, especially if their
primary treatment was endovascular coiling! (Perhaps that is
why they are less cognitively impaired.)
The results are compelling and probably accurate, although
worrisome and discrepant results were that more than 80% of
patients had either severe SAH or intra-axial bleeding (Fisher
Grade 3 and 4), yet an even greater percentage of the 84
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eligible patients were in good neurological condition at pre-
sentation (World Federation of Neurosurgical Societies
Grades 1 and 2). But the good news is that, unlike memory
and concentration deficits arising from brain damage, anxiety
and depression may be treatable and reversible. This is an
article we should send along to our colleagues who are treat-
ing our patients in rehabilitation.
J. Max Findlay
Edmonton, Alberta, Canada
This study shows that emotions may play a substantial rolein the outcome of SAH. A considerable proportion of
patients experienced moderate to severe anxiety and depres-
sion more than 16 months after SAH. The severity of these
emotional disorders was not strongly associated with clinical
indices of brain damage, suggesting that anxiety and depres-
sion result from the life-threatening experience of SAH rather
than from direct consequences of brain damage. Anxiety and
depression were associated with poor psychosocial recovery.
In particular, anxiety seemed to complicate return to work and
engagement in social activities.
The authors propose that anxiety and its adverse impact on
recovery and quality of life can be treated better than physical
or cognitive disabilities with relatively simple and low-cost
means. The levels of anxiety and depression were measured
with standardized questionnaires, which were returned by 52
of the 70 patients. However, all of the patients were inter-
viewed, and on the basis of this information, the authors
inferred that anxious and depressed patients were less likely
to return the standardized questionnaires. Consequently, the
prevalence of anxiety and depression was probably underes-
timated in this population, and similar bias has probably
affected other studies. Severely anxious and depressed pa-
tients may refuse to participate in neuropsychological assess-
ment and other outcome examinations. The findings of this
study indicate that further efforts to clarify the role of emo-
tional disorders in recovery are needed for the optimization of
treatment, rehabilitation, and outcome after SAH.
Juhani Vilkki
Juha Hernesniemi
Helsinki, Finland
Resident Traveling Fellowship in Pediatric Neurosurgery
The Joint Pediatric Neurosurgery Section of the American Association of Neurological
Surgeons and Congress of Neurological Surgeons has established a traveling fellowship
for residents in accredited neurosurgical training programs. The fellowship is intended
to cover the traveling and living expenses for up to 1 month for a resident who wishes
additional experience in pediatric neurosurgery during residency. The 1-month fellow-
ship can be spent at any institution within North America to pursue an activity that
broadens the resident’s exposure to pediatric neurosurgery, including observation at a
clinical or research center, participation in a research project, or any other relevant
activity. Two fellowships per year are awarded on the basis of an evaluation by a
committee of the Joint Pediatric Section. The maximum fellowship stipend is $2500.
The application should include:
1. Statements defining the purpose of the proposed fellowship and an estimate of
expenses that will accrue to the applicant;
2. Permission from the applicant’s residency program director to pursue the 1-month
fellowship if it is awarded;
3. A letter of acceptance from the pediatric neurosurgical program where the applicant
will seek the fellowship.
The deadline for application submission is October 15, 2004. The completed application
should be sent to:
R. Michael Scott, M.D.
Department of Neurosurgery
The Children’s Hospital
300 Longwood Avenue, Bader 319
Boston, MA 02115
(or via email to: michael.scott@tch.harvard.edu)
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